Sucampo (SCMP) Says AMITIZA Had Statistically Significant Results Following Two Phase 3s

Go back to Sucampo (SCMP) Says AMITIZA Had Statistically Significant Results Following Two Phase 3s
Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) Delayed: 18.00 --0 (-0%)
Previous Close $18.00    52 Week High $18.75 
Open $1.35    52 Week Low $9.59 
Day High $18.00    P/E 42.86 
Day Low $18.00    EPS $0.42 
Volume 200